205 related articles for article (PubMed ID: 35121641)
1. Knockout of Factor-Inhibiting HIF (
Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
3. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
[TBL] [Abstract][Full Text] [Related]
4. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
[TBL] [Abstract][Full Text] [Related]
5. The Glucocorticoid Receptor in Intestinal Epithelial Cells Alleviates Colitis and Associated Colorectal Cancer in Mice.
Muzzi C; Watanabe N; Twomey E; Meers GK; Reichardt HM; Bohnenberger H; Reichardt SD
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1505-1518. PubMed ID: 33316454
[TBL] [Abstract][Full Text] [Related]
6. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice.
Kim YE; Lee M; Gu H; Kim J; Jeong S; Yeo S; Lee YJ; Im SH; Sung YC; Kim HJ; Weissman IL; Ahn GO
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29967068
[TBL] [Abstract][Full Text] [Related]
8. TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer.
Etwebi Z; Goldsmith JR; Bou-Dargham M; Tian Y; Hood R; Spitofsky N; Li M; Sun H; Lou Y; Liu S; Lengner C; Chen YH
Inflamm Bowel Dis; 2022 May; 28(5):764-774. PubMed ID: 34894222
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
[TBL] [Abstract][Full Text] [Related]
10. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
[TBL] [Abstract][Full Text] [Related]
11. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
[TBL] [Abstract][Full Text] [Related]
12. The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.
Kennel KB; Burmeister J; Radhakrishnan P; Giese NA; Giese T; Salfenmoser M; Gebhardt JM; Strowitzki MJ; Taylor CT; Wielockx B; Schneider M; Harnoss JM
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509284
[TBL] [Abstract][Full Text] [Related]
13. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function.
Tambuwala MM; Cummins EP; Lenihan CR; Kiss J; Stauch M; Scholz CC; Fraisl P; Lasitschka F; Mollenhauer M; Saunders SP; Maxwell PH; Carmeliet P; Fallon PG; Schneider M; Taylor CT
Gastroenterology; 2010 Dec; 139(6):2093-101. PubMed ID: 20600011
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.
Shah YM; Ito S; Morimura K; Chen C; Yim SH; Haase VH; Gonzalez FJ
Gastroenterology; 2008 Jun; 134(7):2036-48, 2048.e1-3. PubMed ID: 18439915
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis.
Xu P; Xi Y; Zhu J; Zhang M; Luka Z; Stolz DB; Cai X; Xie Y; Xu M; Ren S; Huang Z; Yang D; York JD; Ma X; Xie W
Gastroenterology; 2021 Jul; 161(1):271-286.e11. PubMed ID: 33819483
[TBL] [Abstract][Full Text] [Related]
16. Deletion of cadherin-17 enhances intestinal permeability and susceptibility to intestinal tumour formation.
Chang YY; Yu LC; Yu IS; Jhuang YL; Huang WJ; Yang CY; Jeng YM
J Pathol; 2018 Nov; 246(3):289-299. PubMed ID: 30047135
[TBL] [Abstract][Full Text] [Related]
17. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
[TBL] [Abstract][Full Text] [Related]
18. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS
Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316
[TBL] [Abstract][Full Text] [Related]
19. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
Lavoie S; Chun E; Bae S; Brennan CA; Gallini Comeau CA; Lang JK; Michaud M; Hoveyda HR; Fraser GL; Fuller MH; Layden BT; Glickman JN; Garrett WS
Gastroenterology; 2020 Apr; 158(5):1359-1372.e9. PubMed ID: 31917258
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis.
Flück K; Breves G; Fandrey J; Winning S
Mucosal Immunol; 2016 Mar; 9(2):379-90. PubMed ID: 26220168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
